Skip to content
October 30, 2025
  • VeroSkills Raises $5.3M to Revolutionize AI-Powered Blue-Collar Hiring Amid America’s $1 Trillion Labor Shortage
  • Valthos Raises $30 Million to Make AI the First Line of Defense Against Biological Threats
  • Uluu Raises $16 Million to Turn Seaweed into the Next Global Plastic Alternative
  • Honey Health Secures $7.8M to Deploy Autonomous AI Agents That Transform Healthcare Back Offices
The Times Magazine

THE TIMES MAGAZINE

Worldwide Industry Insights: Leaders Across Continents

Newsletter
Random News
  • News
  • WORLD
    • ISRAEL
    • UNITED STATES
    • UNITED KINGDOM
    • EUROPE
    • SOUTH ASIA
    • INDIA
    • GULF
    • CHINA
    • CANADA
  • Business
  • TECHNOLOGY
  • STARTUPS
  • CEO
  • CXO
  • AWARDS
  • Women Leadership
Headlines
  • VeroSkills Raises $5.3M to Revolutionize AI-Powered Blue-Collar Hiring Amid America’s $1 Trillion Labor Shortage

    6 hours ago
  • Valthos Raises $30 Million to Make AI the First Line of Defense Against Biological Threats

    6 hours ago
  • Uluu Raises $16 Million to Turn Seaweed into the Next Global Plastic Alternative

    6 hours ago
  • Honey Health Secures $7.8M to Deploy Autonomous AI Agents That Transform Healthcare Back Offices

    2 days ago
  • CEO Benny Sørensen, MD, PhD,

    Hemab Therapeutics Raises $157 Million to Transform the Future of Rare Bleeding Disorder Care

    2 days ago2 days ago
  • Polyembo Secures Fresh Funding to Advance “Scrunchy” — a Minimalist Fix for a Complex Vascular Problem

    2 days ago
  • Home
  • My account

My account

Login

Lost your password?

Recent Posts

  • VeroSkills Raises $5.3M to Revolutionize AI-Powered Blue-Collar Hiring Amid America’s $1 Trillion Labor Shortage
  • Valthos Raises $30 Million to Make AI the First Line of Defense Against Biological Threats
  • Uluu Raises $16 Million to Turn Seaweed into the Next Global Plastic Alternative
  • Honey Health Secures $7.8M to Deploy Autonomous AI Agents That Transform Healthcare Back Offices
  • Hemab Therapeutics Raises $157 Million to Transform the Future of Rare Bleeding Disorder Care

The Times Magazine

About Us: The Times Magazine, your premier international magazine and news portal dedicated to featuring the latest news, groundbreaking research, and highlighting exceptional achievements across diverse sectors worldwide. As part of the esteemed PNM Advisors Media unit, we are committed to recognizing and honoring outstanding companies and startups that are making a significant impact in their fields. Our platform celebrates innovation, creativity, and the meaningful contributions that these organizations make to global communities.

At The Times Magazine, we believe in the power of storytelling to inspire and inform. We showcase the remarkable journeys of visionary leaders and entrepreneurs who are shaping industries and driving change. From technology and sustainability to health and culture, our content delves deep into the trends and breakthroughs that define our time.

Contact Us: editor@thetimesmag.com

© 2024 The Times Magazine. All rights reserved. Powered By BlazeThemes.